JPH0460480B2 - - Google Patents

Info

Publication number
JPH0460480B2
JPH0460480B2 JP59176895A JP17689584A JPH0460480B2 JP H0460480 B2 JPH0460480 B2 JP H0460480B2 JP 59176895 A JP59176895 A JP 59176895A JP 17689584 A JP17689584 A JP 17689584A JP H0460480 B2 JPH0460480 B2 JP H0460480B2
Authority
JP
Japan
Prior art keywords
dione
estradiene
hydroxy
estratriene
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59176895A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60105693A (ja
Inventor
Neefu Gyuntaa
Petsutsuoruto Kaaru
Zauaa Geruharuto
Hoofumaisutaa Herumuuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS60105693A publication Critical patent/JPS60105693A/ja
Publication of JPH0460480B2 publication Critical patent/JPH0460480B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/12—Acting on D ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compounds Of Unknown Constitution (AREA)
JP59176895A 1983-08-26 1984-08-27 新規エストラン誘導体およびその製法 Granted JPS60105693A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3331288A DE3331288A1 (de) 1983-08-26 1983-08-26 Neue estran-derivate
DE3331288.5 1983-08-26

Publications (2)

Publication Number Publication Date
JPS60105693A JPS60105693A (ja) 1985-06-11
JPH0460480B2 true JPH0460480B2 (enExample) 1992-09-28

Family

ID=6207824

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59176895A Granted JPS60105693A (ja) 1983-08-26 1984-08-27 新規エストラン誘導体およびその製法

Country Status (5)

Country Link
US (1) US4603013A (enExample)
EP (1) EP0139907B1 (enExample)
JP (1) JPS60105693A (enExample)
AT (1) ATE60785T1 (enExample)
DE (2) DE3331288A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818747A1 (de) * 1988-05-30 1989-12-14 Schering Ag 1(beta),15(alpha)-dihydroxy-1(alpha)-methyl-5(alpha)-androstan-3,17-dion seine herstellung und verwendung
WO1996015253A1 (de) * 1994-11-14 1996-05-23 Schering Aktiengesellschaft Verfahren zur herstellung von 1-hydroxymethyl-1.4-androstadien-3.17-dion
US6523261B1 (en) * 1999-07-22 2003-02-25 Mapress Gmbh & Co. Kg Method of making a metallic press fitting element
CN117659109B (zh) * 2023-11-22 2025-03-25 浙江仙居君业药业有限公司 群勃龙的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3179674A (en) * 1962-01-22 1965-04-20 Olin Mathieson 15-oxygenated estrones and estradiols
DE1223372B (de) * 1963-04-06 1966-08-25 Hoechst Ag Verfahren zur Herstellung von in 15-Stellung substituierten Androstan- und Androsten-Derivaten
US3243355A (en) * 1965-07-30 1966-03-29 American Cyanamid Co Method of hydroxylating 19-nor-androstenedione
US3766224A (en) * 1971-06-03 1973-10-16 Sandoz Ag 15-methyl-substituted steroids
DE2920184A1 (de) * 1979-05-17 1980-11-27 Schering Ag 16 alpha -alkylsteroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
EP0139907A3 (en) 1985-06-05
EP0139907B1 (de) 1991-02-06
US4603013A (en) 1986-07-29
ATE60785T1 (de) 1991-02-15
DE3331288A1 (de) 1985-03-14
JPS60105693A (ja) 1985-06-11
DE3484089D1 (de) 1991-03-14
EP0139907A2 (de) 1985-05-08

Similar Documents

Publication Publication Date Title
JPS6117477B2 (enExample)
JPH0357917B2 (enExample)
US4416985A (en) Process for preparing 3β,7β-dihydroxy-Δ5 -steroids
US5023250A (en) Steroidal 14α-carboxy-alkyl derivatives as regulators of HMG-COA reductase
EP1562974B1 (en) Processes for preparing c-7 substituted 5-androstenes
US4100027A (en) Process for the preparation of 4-androstene-3,17-dione derivatives
US7002028B2 (en) 5-androsten-3β-ol steroid intermediates and processes for their preparation
JPH0460480B2 (enExample)
US4036695A (en) Process for the preparation of estrene-3,17-dione derivatives
IE44308B1 (en) Process for the manufacture of 5-androsten-17-one derivatives and their use
JP4016070B2 (ja) （１１β，１６β）―２１―（アセチルオキシ）―１１―ヒドロキシ―２’―メチル―５’Ｈ―プレグナ―１，４―ジエノ［１７，１６―Ｄ］オキサゾール―３，２０―ジオンの製造
JPS6137280B2 (enExample)
US20040265948A1 (en) Microbial method for hydrolysis and oxidation of androst-5-ene and pregn-5-ene steroid esters
US4100026A (en) Process for the preparation of 4-androstene-3,17-dione derivatives
US3801459A (en) Stereospecific microbiological hydrolysis process
US20060100185A1 (en) 5-Androsten-3beta-ol steroid intermediates and processes for their preparation
US4097334A (en) Process for the preparation of androstane-3,17-dione derivatives
US20070066579A1 (en) 5-androsten-3beta-ol steroid intermediates and processs for their preparation
JPS6319157B2 (enExample)
US3939187A (en) 15α,-Sulfonyloxy-12β-hydroxypregnanes and process for the preparation thereof
US5250712A (en) 1β,15α-dihydroxy-1α-methyl-5α-androstane-3,17-dione, its production and use
EP1679317A2 (en) 5-Androsten-3 -ol steroid intermediates and processes for fheir preparation
JPS59187000A (ja) アンドロスタ−１，４，１１（１２）−トリエン−３，１７−ジオン